Dermapharm Holding SE
XETRA:DMP
Dermapharm Holding SE
Cash from Financing Activities
Dermapharm Holding SE
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Dermapharm Holding SE
XETRA:DMP
|
Cash from Financing Activities
€204.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Cash from Financing Activities
-$8.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bayer AG
XETRA:BAYN
|
Cash from Financing Activities
-€679m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
12%
|
|
Merck KGaA
XETRA:MRK
|
Cash from Financing Activities
-€1.7B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
9%
|
CAGR 10-Years
-5%
|
|
MPH Health Care AG
XETRA:93M1
|
Cash from Financing Activities
-€3.2m
|
CAGR 3-Years
30%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Cash from Financing Activities
-€12.1m
|
CAGR 3-Years
-28%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Dermapharm Holding SE's Cash from Financing Activities?
Cash from Financing Activities
204.5m
EUR
Based on the financial report for Dec 31, 2023, Dermapharm Holding SE's Cash from Financing Activities amounts to 204.5m EUR.
What is Dermapharm Holding SE's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
4%